ESTABLISHING EQUIVALENCE BY SHOWING THAT A SPECIFIED PERCENTAGE OF THE EFFECT OF THE ACTIVE CONTROL OVER PLACEBO IS MAINTAINED
From MaRDI portal
Publication:4512645
Recommendations
- Testing superiority and non-inferiority hypotheses in active controlled clinical trials
- Testing and Selecting for Equivalence With Respect to a Control
- Establishing practical equivalence between three treatments
- Establishing Equivalence of Two Treatments and Sample Size Requirements in Matched-Pairs Design
Cited in
(6)- A group sequential type design for three-arm non-inferiority trials with binary endpoints
- On Non-inferiority Analysis Based On Delta-method Confidence Intervals
- Statistical Issues On Objective, Design, And Analysis Of Noninferiority Active-controlled Clinical Trial
- A test of non null hypothesis for linear trends in proportions
- Bayesian multi-arm de-intensification designs
- Assessing overall evidence from noninferiority trials with shared historical data
This page was built for publication: ESTABLISHING EQUIVALENCE BY SHOWING THAT A SPECIFIED PERCENTAGE OF THE EFFECT OF THE ACTIVE CONTROL OVER PLACEBO IS MAINTAINED
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4512645)